Safety Testing of Adding Nivolumab to Chemotherapy in Patients With Intermediate and High-Risk Local-Regionally Advanced Head and Neck Cancer

UPMC - Shadyside Hospital, Pittsburgh

Inova Fairfax Hospital, Falls Church

Emory University/Winship Cancer Institute, Atlanta

University of Florida Cancer Center at Orlando Health, Orlando

University of Louisville, Louisville

Ohio State University, Columbus

University Hospitals Cleveland Medical Center, Cleveland

University of Wisconsin Hospital and Clinics, Madison

MD Anderson Cancer Center, Houston

Stanford Cancer Institute, Palo Alto

Providence Portland Medical Center, Portland